XML 43 R33.htm IDEA: XBRL DOCUMENT
v3.26.1

Fair value measurements (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Fair Value Disclosures [Abstract] |
Schedule of Investments in Company-Sponsored Funds | The following table provides information about the Company's investments in Company-sponsored funds as of March 31, 2026:
(Expressed in thousands) |  |  |  |  |  |  |
| Fair Value |  | Unfunded Commitments |  | Redemption Frequency |  | Redemption Notice Period
Private equity funds (1) | $ | 10,543 |  |  | $ | 741 |  |  | N/A |  | N/A
| $ | 10,543 |  |  | $ | 741 |  |  |  |  |
(1) Private equity funds include portfolios focused on technology, infrastructure, real estate, natural resources and specific co-investment opportunities The following table provides information about the Company's investments in Company-sponsored funds as of December 31, 2025:
(Expressed in thousands) |  |  |  |  |  |  |
| Fair Value |  | Unfunded Commitments |  | Redemption Frequency |  | Redemption Notice Period
Private equity funds (2) | $ | 5,555 |  |  | $ | 741 |  |  | N/A |  | N/A
| $ | 5,555 |  |  | $ | 741 |  |  |  |  |
(1) Private equity funds includes portfolios focused on technology, infrastructure, real estate, natural resources and specific co-investment opportunities
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis and Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis | The Company's assets and liabilities, recorded at fair value on a recurring basis as of March 31, 2026 and December 31, 2025, have been categorized based upon the above fair value hierarchy as follows: Assets and liabilities measured at fair value on a recurring basis as of March 31, 2026:
(Expressed in thousands) |  |  |  |  |  |  |
| Fair Value Measurements as of March 31, 2026
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |
Deposits with clearing organizations | $ | 28,237 |  |  | $ | — |  |  | $ | — |  |  | $ | 28,237 |
Securities owned: |  |  |  |  |  |  |
U.S. Treasury securities | 1,160,684 |  |  | — |  |  | — |  |  | 1,160,684 |
U.S. Agency securities | — |  |  | 5,878 |  |  | — |  |  | 5,878 |
Sovereign obligations | — |  |  | 5,316 |  |  | — |  |  | 5,316 |
Corporate debt and other obligations | — |  |  | 7,990 |  |  | 2,153 |  |  | 10,143 |
Mortgage and other asset-backed securities | — |  |  | 2,140 |  |  | — |  |  | 2,140 |
Municipal obligations | — |  |  | 28,350 |  |  | — |  |  | 28,350 |
Convertible bonds | — |  |  | 17,826 |  |  | — |  |  | 17,826 |
Corporate equities | 29,053 |  |  | — |  |  | 1,170 |  |  | 30,223 |
Money markets | 5,000 |  |  | 230 |  |  | — |  |  | 5,230 |
Other debt securities (3) | — |  |  | — |  |  | 128 |  |  | 128 |
Securities owned, at fair value | 1,194,737 |  |  | 67,730 |  |  | 3,451 |  |  | 1,265,918 |
Investments (1) | 1,600 |  |  | 10,499 |  |  | 17,000 |  |  | 29,099 |
Loans (1) | — |  |  | 296 |  |  | — |  |  | 296 |
Derivative contracts: (2) |  |  |  |  |  |  |
TBAs | — |  |  | 98 |  |  | — |  |  | 98 |
Derivative contracts, total | — |  |  | 98 |  |  | — |  |  | 98 |
Total | $ | 1,224,574 |  |  | $ | 78,623 |  |  | $ | 20,451 |  |  | $ | 1,323,648 |
Liabilities |  |  |  |  |  |  |
Securities sold but not yet purchased: |  |  |  |  |  |  |
U.S. Treasury securities | $ | 209,798 |  |  | $ | — |  |  | $ | — |  |  | $ | 209,798 |
U.S. Agency securities | — |  |  | 2 |  |  | — |  |  | 2 |
Sovereign obligations | — |  |  | 997 |  |  | — |  |  | 997 |
Corporate debt and other obligations | — |  |  | 1,275 |  |  | — |  |  | 1,275 |
Convertible bonds | — |  |  | 10,652 |  |  | — |  |  | 10,652 |
Corporate equities | 9,080 |  |  | — |  |  | — |  |  | 9,080 |
Securities sold but not yet purchased, at fair value | 218,878 |  |  | 12,926 |  |  | — |  |  | 231,804 |
Derivative contracts: (2) |  |  |  |  |  |  |
Futures | 3,812 |  |  | — |  |  | — |  |  | 3,812 |
TBAs | — |  |  | 92 |  |  | — |  |  | 92 |
Derivative contracts, total | 3,812 |  |  | 92 |  |  | — |  |  | 3,904 |
Total | $ | 222,690 |  |  | $ | 13,018 |  |  | $ | — |  |  | $ | 235,708 |
(1) Included in other assets on the condensed consolidated balance sheet (2) Included in receivables from/payables to brokers, dealers and clearing organizations on the condensed consolidated balance sheet (3) Represents auction rate securities that failed in the auction rate market Assets and liabilities measured at fair value on a recurring basis as of December 31, 2025:
(Expressed in thousands) |  |  |  |  |  |  |
| Fair Value Measurements as of December 31, 2025
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |
Deposits with clearing organizations | $ | 27,996 |  |  | $ | — |  |  | $ | — |  |  | $ | 27,996 |
Securities owned: |  |  |  |  |  |  |
U.S. Treasury securities | 1,151,564 |  |  | — |  |  | — |  |  | 1,151,564 |
U.S. Agency securities | — |  |  | 5,925 |  |  | — |  |  | 5,925 |
Sovereign obligations | — |  |  | 1,223 |  |  | — |  |  | 1,223 |
Corporate debt and other obligations | — |  |  | 3,989 |  |  | 2,064 |  |  | 6,053 |
Mortgage and other asset-backed securities | — |  |  | 2,109 |  |  | — |  |  | 2,109 |
Municipal obligations | — |  |  | 28,926 |  |  | — |  |  | 28,926 |
Convertible bonds | — |  |  | 20,500 |  |  | — |  |  | 20,500 |
Corporate equities | 28,200 |  |  | — |  |  | 1,170 |  |  | 29,370 |
Money markets | 5,000 |  |  | 4 |  |  | — |  |  | 5,004 |
Other debt securities (3) | — |  |  | — |  |  | 128 |  |  | 128 |
Securities owned, at fair value | 1,184,764 |  |  | 62,676 |  |  | 3,362 |  |  | 1,250,802 |
Investments (1) | 1,600 |  |  | 13,695 |  |  | 17,000 |  |  | 32,295 |
Loans (1) | — |  |  | 653 |  |  | — |  |  | 653 |
Derivative contracts: (2) |  |  |  |  |  |  |
TBAs | — |  |  | 34 |  |  | — |  |  | 34 |
Derivative contracts, total | — |  |  | 34 |  |  | — |  |  | 34 |
Total | $ | 1,214,360 |  |  | $ | 77,058 |  |  | $ | 20,362 |  |  | $ | 1,311,780 |
Liabilities |  |  |  |  |  |  |
Securities sold but not yet purchased: |  |  |  |  |  |  |
U.S. Treasury securities | $ | 155,518 |  |  | $ | — |  |  | $ | — |  |  | $ | 155,518 |
U.S. Agency securities | — |  |  | 1 |  |  | — |  |  | 1 |
Sovereign obligations | — |  |  | 2,410 |  |  | — |  |  | 2,410 |
Corporate debt and other obligations | — |  |  | 1,965 |  |  | — |  |  | 1,965 |
Convertible bonds | — |  |  | 6,096 |  |  | — |  |  | 6,096 |
Corporate equities | 9,722 |  |  | — |  |  | — |  |  | 9,722 |
Securities sold but not yet purchased, at fair value | 165,240 |  |  | 10,472 |  |  | — |  |  | 175,712 |
Derivative contracts: (2) |  |  |  |  |  |  |
Futures | 133 |  |  | — |  |  | — |  |  | 133 |
TBAs | — |  |  | 27 |  |  | — |  |  | 27 |
Derivative contracts, total | 133 |  |  | 27 |  |  | — |  |  | 160 |
Total | $ | 165,373 |  |  | $ | 10,499 |  |  | $ | — |  |  | $ | 175,872 |
(1) Included in other assets on the condensed consolidated balance sheet (2) Included in receivables from/payables to brokers, dealers and clearing organizations (3) Represents auction rate securities that failed in the auction rate market The following tables present changes in Level 3 assets and liabilities measured at fair value on a recurring basis for three-months periods ended March 31, 2026 and 2025:
(Expressed in thousands) |  |  |  |  |  |  |  |  |
|  | Level 3 Assets and Liabilities
|  | For the Three Months Ended March 31, 2026
|  |  |  | Total Realized |  |  |  |  |  |  |  |
|  | Beginning |  | and Unrealized |  | Purchases |  | Sales and |  | Transfers |  | Ending
|  | Balance |  | Gain (2) |  | and Issuances |  | Settlements |  | In (Out) |  | Balance
Assets |  |  |  |  |  |  |  |  |  |  |
Corporate debt and other obligations | 1,170 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,170 |
Corporate equities | 2,064 |  |  | 89 |  |  | — |  |  | — |  |  | — |  |  | 2,153 |
Private equity securities (3) | 17,000 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 17,000 |
Other debt securities (1) | 128 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 128 |
(1) Represents auction rate securities that failed in the auction rate market (2) Included in principal transactions in the condensed consolidated income statement except amounts for corporate and other obligations, which represent paid-in-kind interest, that are included in interest income in the condensed consolidated income statement (3) Represents equity security associated with a consolidated private equity fund sponsored by the Company
(Expressed in thousands) |  |  |  |  |  |  |  |  |
|  | Level 3 Assets and Liabilities
|  | For the Three Months Ended March 31, 2025
|  |  |  | Total Realized |  |  |  |  |  |  |  |
|  | Beginning |  | and Unrealized |  | Purchases |  | Sales and |  | Transfers |  | Ending
|  | Balance |  | Gain (2) |  | and Issuances |  | Settlements |  | In (Out) |  | Balance
Assets |  |  |  |  |  |  |  |  |  |  |
Trade claims |  | $ | 2,684 |  |  | $ | — |  |  | $ | 534 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,218 |
Other debt securities (1) | 2,652 |  |  | 206 |  |  | — |  |  | (2,730) |  |  | — |  |  | 128 |
(1) Represents auction rate securities that failed in the auction rate market (2) Included in principal transactions in the condensed consolidated income statement
Schedule of Assets and Liabilities Not Measured at Fair Value | Assets and liabilities not measured at fair value as of March 31, 2026:
(Expressed in thousands) |  |  | Fair Value Measurement: Assets
| Carrying Value |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Cash and cash equivalents | $ | 34,601 |  |  | $ | 34,601 |  |  | $ | — |  |  | $ | — |  |  | $ | 34,601 |
Deposits with clearing organizations | 85,993 |  |  | 85,993 |  |  | — |  |  | — |  |  | 85,993 |
Receivables from brokers, dealers and clearing organizations: |  |  |  |  |  |  |  |  |
Securities borrowed | 158,057 |  |  | — |  |  | 158,057 |  |  | — |  |  | 158,057 |
Receivables from brokers | 48,775 |  |  | — |  |  | 48,775 |  |  | — |  |  | 48,775 |
Securities failed to deliver | 20,360 |  |  | — |  |  | 20,360 |  |  | — |  |  | 20,360 |
Clearing organizations | 28,846 |  |  | — |  |  | 28,846 |  |  | — |  |  | 28,846 |
Trade date receivables | 33,430 |  |  | — |  |  | 33,430 |  |  | — |  |  | 33,430 |
Other | 5,810 |  |  | — |  |  | 5,810 |  |  | — |  |  | 5,810 |
| 295,278 |  |  | — |  |  | 295,278 |  |  | — |  |  | 295,278 |
Receivables from customers | 1,483,755 |  |  | — |  |  | 1,483,755 |  |  | — |  |  | 1,483,755 |
Notes receivable, net | 55,137 |  |  | — |  |  | 55,137 |  |  |  |  | 55,137 |
Company-owned life insurance | 106,144 |  |  | — |  |  | 106,144 |  |  | — |  |  | 106,144 |
Investments (1) | 2,924 |  |  | — |  |  | 2,924 |  |  | — |  |  | 2,924 |
(1) Included within other assets on the condensed consolidated balance sheet
(Expressed in thousands) |  |  | Fair Value Measurement: Liabilities
| Carrying Value |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Drafts payable | $ | 19,754 |  |  | $ | 19,754 |  |  | $ | — |  |  | $ | — |  |  | $ | 19,754 |
Bank call loans | 287,900 |  |  | — |  |  | 287,900 |  |  | — |  |  | 287,900 |
Payables to brokers, dealers and clearing organizations: |  |  |  |  |  |  |  |  |
Securities loaned | 320,163 |  |  | — |  |  | 320,163 |  |  | — |  |  | 320,163 |
Payables to brokers | 1,136 |  |  | — |  |  | 1,136 |  |  | — |  |  | 1,136 |
Securities failed to receive | 49,557 |  |  | — |  |  | 49,557 |  |  | — |  |  | 49,557 |
Clearing organization and other | 173 |  |  | — |  |  | 173 |  |  | — |  |  | 173 |
| 371,029 |  |  | — |  |  | 371,029 |  |  | — |  |  | 371,029 |
Payables to customers | 376,343 |  |  | — |  |  | 376,343 |  |  | — |  |  | 376,343 |
Securities sold under agreements to repurchase | 968,346 |  |  | — |  |  | 968,346 |  |  | — |  |  | 968,346 |
Assets and liabilities not measured at fair value as of December 31, 2025:
(Expressed in thousands) |  |  | Fair Value Measurement: Assets
| Carrying Value |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Cash and cash equivalents | $ | 38,405 |  |  | $ | 38,405 |  |  | $ | — |  |  | $ | — |  |  | $ | 38,405 |
Deposits with clearing organizations | 79,611 |  |  | 79,611 |  |  | — |  |  | — |  |  | 79,611 |
Receivables from brokers, dealers and clearing organizations: |  |  |  |  |  |  |  |  |
Securities borrowed | 160,006 |  |  | — |  |  | 160,006 |  |  | — |  |  | 160,006 |
Receivables from brokers | 51,080 |  |  | — |  |  | 51,080 |  |  | — |  |  | 51,080 |
Securities failed to deliver | 2,583 |  |  | — |  |  | 2,583 |  |  | — |  |  | 2,583 |
Clearing organizations | 27,215 |  |  | — |  |  | 27,215 |  |  | — |  |  | 27,215 |
Trade date receivables | 14,800 |  |  | — |  |  | 14,800 |  |  | — |  |  | 14,800 |
Other | 4,283 |  |  | — |  |  | 4,283 |  |  | — |  |  | 4,283 |
| 259,967 |  |  | — |  |  | 259,967 |  |  | — |  |  | 259,967 |
Receivables from customers | 1,415,049 |  |  | — |  |  | 1,415,049 |  |  | — |  |  | 1,415,049 |
Notes receivable, net | 57,965 |  |  | — |  |  | 57,965 |  |  | — |  |  | 57,965 |
Company-owned life insurance | 109,094 |  |  | — |  |  | 109,094 |  |  | — |  |  | 109,094 |
Investments (1) | 2,114 |  |  | — |  |  | 2,114 |  |  | — |  |  | 2,114 |
(1) Included within other assets on the condensed consolidated balance sheet
(Expressed in thousands) |  |  | Fair Value Measurement: Liabilities
| Carrying Value |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Drafts payable | $ | 18,347 |  |  | $ | 18,347 |  |  | $ | — |  |  | $ | — |  |  | $ | 18,347 |
Bank call loans | 76,800 |  |  | — |  |  | 76,800 |  |  | — |  |  | 76,800 |
Payables to brokers, dealers and clearing organizations: |  |  |  |  |  |  |  |  |
Securities loaned | 370,331 |  |  | — |  |  | 370,331 |  |  | — |  |  | 370,331 |
Payables to brokers | 728 |  |  | — |  |  | 728 |  |  | — |  |  | 728 |
Securities failed to receive | 18,937 |  |  | — |  |  | 18,937 |  |  | — |  |  | 18,937 |
Clearing organizations and other | 7,841 |  |  | — |  |  | 7,841 |  |  | — |  |  | 7,841 |
| 397,837 |  |  | — |  |  | 397,837 |  |  | — |  |  | 397,837 |
Payables to customers | 393,694 |  |  | — |  |  | 393,694 |  |  | — |  |  | 393,694 |
Securities sold under agreements to repurchase | 997,192 |  |  | — |  |  | 997,192 |  |  | — |  |  | 997,192 |
Schedule of Notional Amounts and Fair Values of Derivatives by Product | The notional amounts and fair values of the Company's derivatives as of March 31, 2026 and December 31, 2025 by product were as follows:
(Expressed in thousands) |  |  |  |  |
| Fair Value of Derivative Instruments as of March 31, 2026
| Description |  | Notional |  | Fair Value
Assets: |  |  |  |  |
Derivatives not designated as hedging instruments (1) |  |  |  |  |
Other contracts | TBAs |  | $ | 20,075 |  |  | $ | 98 |
|  |  | $ | 20,075 |  |  | $ | 98 |
Liabilities: |  |  |  |  |
Derivatives not designated as hedging instruments (1) |  |  |  |  |
Commodity contracts | Futures |  | $ | 14,420,000 |  |  | $ | 3,812 |
Other contracts | TBAs |  | 20,075 |  |  | 92 |
|  |  | $ | 14,440,075 |  |  | $ | 3,904 |
(1)See "Derivative Instruments and Hedging Activities" above for a description of derivative financial instruments. Such derivative instruments are not subject to master netting agreements, thus the related amounts are not offset.
(Expressed in thousands) |  |  |  |  |
| Fair Value of Derivative Instruments as of December 31, 2025
| Description |  | Notional |  | Fair Value
Assets: |  |  |  |  |
Derivatives not designated as hedging instruments (1) |  |  |  |  |
Other contracts | TBAs |  | $ | 9,900 |  |  | $ | 34 |
|  |  | $ | 9,900 |  |  | $ | 34 |
Liabilities: |  |  |  |  |
Derivatives not designated as hedging instruments (1) |  |  |  |  |
Commodity contracts | Futures |  | $ | 13,960,000 |  |  | $ | 133 |
Other contracts | TBAs |  | 9,900 |  |  | 27 |
|  |  | $ | 13,969,900 |  |  | $ | 160 |
(1)See "Derivative Instruments and Hedging Activities" above for a description of derivative financial instruments. Such derivative instruments are not subject to master netting agreements, thus the related amounts are not offset.
Schedule of Fair Value Amounts of Derivative Instruments and their Effect on Consolidated Income Statements | The following table presents the location and fair value amounts of the Company's derivative instruments and their effect in the condensed consolidated income statements for the three months ended March 31, 2026 and 2025:
(Expressed in thousands) |  |  |  |  |  |
|  | The Effect of Derivative Instruments in the Income Statement
|  | For the Three Months Ended March 31, 2026
|  |  |  | Recognized in Income on Derivatives (pre-tax)
Types |  | Description |  | Location |  | Net Gain/(Loss)
Commodity contracts |  | Futures |  | Principal transactions revenue, net |  | $ | 3,929 |
Other contracts |  | Foreign exchange forward contracts |  | Other revenue/(Compensation and related expenses) |  | 2 |
Other contracts |  | TBAs |  | Principal transactions revenue, net |  | (2) |
|  |  |  |  |  | $ | 3,929 |
(Expressed in thousands) |  |  |  |  |  |
|  | The Effect of Derivative Instruments in the Income Statement
|  | For the Three Months Ended March 31, 2025
|  |  |  | Recognized in Income on Derivatives (pre-tax)
Types |  | Description |  | Location |  | Net Loss
Commodity contracts |  | Futures |  | Principal transactions revenue, net |  | $ | (1,138) |
|  |  |  |  |  | $ | (1,138) |

X
- Definition [Table Text Block] for Financial Instruments, Estimate Not Practicable, Fair Value [Table] + References No definition available. + Details
Name: | opy_FinancialInstrumentsEstimateNotPracticableFairValueTableTextBlock
Namespace Prefix: | opy_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of sponsored fund investments. + References No definition available. + Details
Name: | opy_ScheduleOfSponsoredFundInvestmentsTableTableTextBlock
Namespace Prefix: | opy_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 182 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480401/815-10-55-182 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C + Details
Name: | us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration